Your browser doesn't support javascript.
loading
A turning point in therapy for ameloblastomas.
Abe, Masanobu; Zong, Liang; Abe, Takahiro; Hoshi, Kazuto.
Affiliation
  • Abe M; Department of Oral & Maxillofacial Surgery, University of Tokyo Hospital, Tokyo, Japan; Division for Health Service Promotion, University of Tokyo, Tokyo, Japan. Electronic address: abem-ora@h.u-tokyo.ac.jp.
  • Zong L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China; Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Abe T; Department of Oral & Maxillofacial Surgery, University of Tokyo Hospital, Tokyo, Japan.
  • Hoshi K; Department of Oral & Maxillofacial Surgery, University of Tokyo Hospital, Tokyo, Japan.
Oral Oncol ; 80: 95-96, 2018 05.
Article in En | MEDLINE | ID: mdl-29548681
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oximes / Ameloblastoma / Jaw Neoplasms / Protein Kinase Inhibitors / Imidazoles / Antineoplastic Agents Limits: Humans Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oximes / Ameloblastoma / Jaw Neoplasms / Protein Kinase Inhibitors / Imidazoles / Antineoplastic Agents Limits: Humans Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2018 Document type: Article